arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Balance Labs, Inc.

BLNC
Price unavailable
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
48 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
52
Health
Fair
Bullish
auto_awesome

Analytical Summary

Balance Labs, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC 13.4%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

48-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$32.67K
↓ -27.4%
Net Income Profit after all expenses
$177.80K
↑ +100.6%
Operating Margin Operating profit as % of sales
-44.2%
↓ -170.0%
FCF / Share Free cash flow per share
$-0.00
↓ -191.1%
Long-Term Debt Long-term obligations
$25.00K
↓ -95.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health
66
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 48 quarters